Therapeutic Potential of the Hsp90/Cdc37 Interaction in Neurodegenerative Diseases

Frontiers in Neuroscience - Switzerland
doi 10.3389/fnins.2019.01263
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Frontiers Media SA

Related search

Therapeutic Potential of Genipin in Central Neurodegenerative Diseases

CNS Drugs
PsychiatryMental HealthNeurologyPharmacology
2016English

Targeting the Hsp90-Cdc37-Client Protein Interaction to Disrupt Hsp90 Chaperone Machinery

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

New Therapeutic Strategy for the Neurodegenerative Diseases: Pharmacological Modulation of Ca2+/Camp Signaling Interaction

International Archives of Clinical Pharmacology
2018English

Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases

ASN Neuro
NeuroscienceNeurology
2019English

Neurodegenerative Diseases: Multifactorial Conformational Diseases and Their Therapeutic Interventions

Journal of Neurodegenerative Diseases
Neurology
2013English

Protein Misfolding in Neurodegenerative Diseases. Mechanisms and Therapeutic Strategies

Biochemistry (Moscow)
BiochemistryMedicine
2008English

Rhodopsin: A Potential Biomarker for Neurodegenerative Diseases

Frontiers in Neuroscience
Neuroscience
2020English

Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases

Frontiers in Neurology
Neurology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy